Camascope (formerly named VCare Systems) Revenue and Competitors
Employee Data
- Camascope (formerly named VCare Systems) has 43 Employees.
- Camascope (formerly named VCare Systems) grew their employee count by 39% last year.
Camascope (formerly named VCare Systems)'s People
Name | Title | Email/Phone |
---|
Camascope (formerly named VCare Systems) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 82 | 32% | N/A | N/A |
#2 | N/A | 35 | 46% | N/A | N/A |
#3 | $15M | 185 | -5% | N/A | N/A |
#4 | N/A | 131 | 138% | N/A | N/A |
#5 | N/A | 134 | 29% | N/A | N/A |
#6 | N/A | 54 | 26% | N/A | N/A |
#7 | N/A | 1 | -86% | N/A | N/A |
#8 | N/A | 50 | 28% | N/A | N/A |
#9 | N/A | 49 | 29% | N/A | N/A |
#10 | N/A | 233 | 23% | N/A | N/A |
What Is Camascope (formerly named VCare Systems)?
We have officially changed our name to Camascope from VCare Systems. The prefix \Cama\ stands for Care and Medicine Administration, which are the processes that our products are designed to enhance. \n\nCamascope's mission is to connect the dots in care through integrated and user-friendly software.\n\nOur electronic medication product digitises the medication records of care home and community patients, communicating this information to pharmacies, GPs and other stakeholders, reducing any communication gaps. The Camascope pharmacy solution enhances this connected approach.\n\nCamascope's remote monitoring solution enables vital sign recording from connected medical devices to be seamlessly communicated to GPs from a care home and community care setting.\n\nFor any enquiry please reach out to us on info@camascope.com
keywords:N/AN/A
Total Funding
43
Number of Employees
N/A
Revenue (est)
39%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $4.1M | 43 | -40% | N/A |
#2 | $4.1M | 43 | 16% | N/A |
#3 | $4.1M | 43 | 13% | N/A |
#4 | $8.7M | 43 | 8% | N/A |
#5 | $7.8M | 43 | -9% | N/A |